Compare Novavax Inc (NVAX) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Wix.Com Ltd — how do they compare? Novavax Inc trades at $8.11 (market cap $1.30B), while Wix.Com Ltd trades at $51.4 (market cap $2.23B). The key difference: Wix.Com Ltd is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| NVAX | WIX | |
|---|---|---|
Market Cap | $1.30B | $2.23B |
Sector | Health | Technology |
52-Week High | $11.19 | $184.24 |
52-Week Low | $6.22 | $40.43 |
Enterprise Value | $800.50M | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
Wix.com trades at $51.12, down 0.64% on the day, with a mixed technical outlook showing bullish moving averages but overbought RSI levels. Revenue growth remains strong, reaching $1.99B in 2025, though net income margin turned negative at -1.97%. Recent news includes product launches like Wix Headless AI integration and multiple law firm investigations into potential securities fraud following a 56% stock decline in H1 2026.
The stock presents a high-risk, high-reward profile with a consensus price target of $77.50 implying 52% upside, but faces headwinds from earnings volatility, negative equity, and legal scrutiny. Long-term growth drivers in AI and small business tools are countered by near-term execution risks and competitive pressures in the website-building space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
